Industry Support Related News

Meet Dr. Terri Shieh-Newton, life sciences patent attorney

SynBioBeta had the privilege of talking with Terri Shieh-Newton, life sciences patent attorney and partner at Mintz Levin, who discussed with us her background and expertise, as well as advice for entrepreneurs in the synbio space. What are some of [...]

By | September 20th, 2017|Advocacy/Trade, Industry Support, News|

From the Lab to the Marketplace: Creating Business Opportunities for Synthetic Biologists

This week we interviewed James Hallinan, Business Development Manager of Synthetic Biology at Cambridge Consultants, who will be speaking in the session What’s Your Bio-Strategy? (sponsored by Ginkgo Bioworks) at SynBioBeta SF 2017 on October 3rd. With a strong commercial [...]

By | September 20th, 2017|Industry Support, News, Science and Beyond|

3rd Annual Engineering Biology Award Winners Announced

George Church, James Collins, and Reshma Shetty Recognized as Synthetic Biology Innovators SAN FRANCISCO, September 19, 2017 – The Engineering Biology Awards will recognize excellence in synthetic biology at the Mission Bay Conference Center on October 4. This year’s [...]

Why M Ventures is Investing in Synthetic Biology Companies – Meet Andreas Jurgeit

This week we interviewed someone who is passionate about startups that are transforming innovative ideas into commercial success with real-world benefits, as well as new ideas around life science technologies. Andreas Jurgeit, Investment Director of the Life Science team at [...]

By | September 16th, 2017|Financial Services, Industry Support, News|

Sean O’Sullivan at IndieBio’s 5th Demo Day

Every single one of us on this stage is touched by the challenges that we all face in life sciences. Which is why with IndieBio we aim to tackle all these really challenging and incredibly important issues not just [...]

Bioeconomy Fund 1 completes $8.3M of investments in six companies that are building critical infrastructure for the 21st century global economy.

SEATTLE, Washington – Sep 13, 2017 – Bioeconomy Capital announces that Fund 1 is fully invested. Fund 1 portfolio companies exemplify the breadth and impact of biological technologies on consumers, businesses, and markets. Bioeconomy Capital engages at an early [...]

By | September 14th, 2017|Financial Services, Industry Support, News, Press Releases|